Exploring Grid Dynamics Holdings And Two High Growth Tech Stocks

Over the last 7 days, the market has dropped 1.4%, but it is up 21% over the past year with earnings forecast to grow by 15% annually. In this dynamic environment, identifying high growth tech stocks such as Grid Dynamics Holdings can be crucial for investors looking to capitalize on robust earnings potential and market resilience.

Advertisement

Top 10 High Growth Tech Companies In The United States

NameRevenue GrowthEarnings GrowthGrowth Rating
TG Therapeutics28.39%43.54%★★★★★★
Super Micro Computer20.62%27.13%★★★★★★
Sarepta Therapeutics24.22%44.94%★★★★★★
Ardelyx27.44%65.50%★★★★★★
G1 Therapeutics27.57%57.75%★★★★★★
Invivyd42.91%70.39%★★★★★★
Amicus Therapeutics20.45%61.85%★★★★★★
Ascendis Pharma39.87%68.71%★★★★★★
Seagen22.57%71.80%★★★★★★
ImmunoGen26.00%45.85%★★★★★★

Click here to see the full list of 248 stocks from our US High Growth Tech and AI Stocks screener.

Let's review some notable picks from our screened stocks.

Grid Dynamics Holdings (NasdaqCM:GDYN)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: Grid Dynamics Holdings, Inc. provides technology consulting, platform and product engineering, and analytics services globally and has a market cap of approximately $1.03 billion.

Operations: Grid Dynamics Holdings, Inc. generates revenue primarily from its computer services segment, which accounted for $318.34 million. The company's operations span North America, Europe, and other international markets.

Grid Dynamics Holdings has demonstrated significant growth potential, with a forecasted annual revenue increase of 14%, surpassing the US market's average. Their innovative AI-powered Data Observability Starter Kit enhances data quality across diverse platforms, crucial for data-driven decision-making. Despite a net loss of $0.82 million in Q2 2024, their R&D expenses contribute to long-term growth, with earnings expected to grow 105.85% annually. The company’s forward-looking strategy includes robust product offerings and seamless integration capabilities, supporting enterprise-scale clients effectively.

NasdaqCM:GDYN Earnings and Revenue Growth as at Sep 2024
NasdaqCM:GDYN Earnings and Revenue Growth as at Sep 2024

Savara (NasdaqGS:SVRA)

Simply Wall St Growth Rating: ★★★★★☆

Overview: Savara Inc. is a clinical-stage biopharmaceutical company specializing in rare respiratory diseases with a market cap of $692.97 million.

Operations: Savara Inc. focuses on developing therapies for rare respiratory diseases. The company is currently in the clinical stage and does not yet generate revenue from product sales.

Savara's revenue is forecasted to grow at an impressive 66.5% per year, significantly outpacing the US market's average of 8.7%. Despite reporting a net loss of $22.24 million in Q2 2024, the company's earnings are expected to increase by 55.67% annually, with profitability anticipated within three years. Their recent Phase 3 IMPALA-2 clinical trial results for molgramostim showed statistically significant improvements and durability of effect, bolstering future growth prospects in the biotech sector.

NasdaqGS:SVRA Revenue and Expenses Breakdown as at Sep 2024
NasdaqGS:SVRA Revenue and Expenses Breakdown as at Sep 2024

DoubleVerify Holdings (NYSE:DV)

Simply Wall St Growth Rating: ★★★★☆☆

Overview: DoubleVerify Holdings, Inc. offers a software platform for digital media measurement and data analytics in the United States and internationally, with a market cap of $3.29 billion.

Operations: DoubleVerify Holdings generates revenue primarily from its data processing services, amounting to $612.88 million. The company focuses on providing digital media measurement and analytics solutions across various markets.

DoubleVerify Holdings’ earnings are expected to grow at 23.5% annually, outpacing the US market's average of 15%. The company's revenue is forecasted to increase by 15.3% per year, with recent Q2 sales reaching $155.89 million, up from $133.74 million a year ago. Notably, DoubleVerify has invested significantly in R&D to enhance its AI-driven ad verification solutions, with expenses contributing to their innovative offerings like DV Authentic Marketplace and partnerships with firms like Taboola and Pinterest for brand safety measures.

NYSE:DV Revenue and Expenses Breakdown as at Sep 2024
NYSE:DV Revenue and Expenses Breakdown as at Sep 2024

Taking Advantage

  • Navigate through the entire inventory of 248 US High Growth Tech and AI Stocks here.
  • Hold shares in these firms? Setup your portfolio in Simply Wall St to seamlessly track your investments and receive personalized updates on your portfolio's performance.
  • Take control of your financial future using Simply Wall St, offering free, in-depth knowledge of international markets to every investor.

Ready For A Different Approach?

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.

New: Manage All Your Stock Portfolios in One Place

We've created the ultimate portfolio companion for stock investors, and it's free.

• Connect an unlimited number of Portfolios and see your total in one currency
• Be alerted to new Warning Signs or Risks via email or mobile
• Track the Fair Value of your stocks

Try a Demo Portfolio for Free

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com

About NYSE:DV

DoubleVerify Holdings

Provides media effectiveness platforms in the United States.

Flawless balance sheet and fair value.

Advertisement

Weekly Picks

CE
Ceazar
SPAI.F logo
Ceazar on Sparc AI ·

When GPS fails: this small cap is fixing a $54B drone problem

Fair Value:US$3.8756.3% undervalued
13 users have followed this narrative
0 users have commented on this narrative
3 users have liked this narrative
BL
BlackGoat
IREN logo
BlackGoat on IREN ·

IREN's Bold Moves in Sustainable Bitcoin Mining & AI Data Centers

Fair Value:US$71.4852.5% undervalued
212 users have followed this narrative
8 users have commented on this narrative
32 users have liked this narrative
HE
HedgeY
ARM logo
HedgeY on Arm Holdings ·

The Architecture Layer of AI Computing - But Priced Like the Future Already Arrived?

Fair Value:US$43043.1% undervalued
17 users have followed this narrative
1 users have commented on this narrative
4 users have liked this narrative
HI
Hidden_Rock_Capital
FISV logo
Hidden_Rock_Capital on Fiserv ·

Temporary "perfect storm" leads to opportunity to buy financial services leader for less than 5x long-term earnings

Fair Value:US$119.9954.8% undervalued
23 users have followed this narrative
0 users have commented on this narrative
9 users have liked this narrative

Updated Narratives

PR
PrashhD
AURIONPRO logo
PrashhD on Aurionpro Solutions ·

Aurionpro Solutions: Is the Market Mispricing One of India's Most Interesting Fintech Product Companies?

Fair Value:₹1k27.1% undervalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative
NE
LOT logo
newsfinder11221 on Lotus Technology ·

Lotus Technology: A Technology-Driven Luxury EV Brand with a Promising Turnaround Story

Fair Value:US$2.462.9% undervalued
1 users have followed this narrative
2 users have commented on this narrative
0 users have liked this narrative
ON
AIIO logo
Ontological on Robo.ai ·

Robo.ai and Abu Dhabi Enterprise Jointly Establish AI Industrial Group Alif Holding to Serve Infrastructure, Government and Industrial Secto

Fair Value:US$0.0026117.2k% overvalued
1 users have followed this narrative
0 users have commented on this narrative
0 users have liked this narrative

Popular Narratives

CU
MSFT logo
CubanEros on Microsoft ·

A wonderful business at reasonable price.

Fair Value:US$419.916.3% undervalued
93 users have followed this narrative
0 users have commented on this narrative
7 users have liked this narrative
OS
oscargarcia
NVDA logo
oscargarcia on NVIDIA ·

The company that went from selling GPUs to gamers to becoming the AI arms dealer of the 21st century.

Fair Value:US$28029.6% undervalued
207 users have followed this narrative
9 users have commented on this narrative
15 users have liked this narrative
BE
PYPL logo
benjamin_lvieq on PayPal Holdings ·

PayPal: PayPal Doesn't Need to Grow – It Needs to Stop Falling – A Mispriced Cash Machine With a Cannibal Buyback

Fair Value:US$6510.3% undervalued
73 users have followed this narrative
2 users have commented on this narrative
11 users have liked this narrative

Trending Discussion

DE
TDOC logo
derek_3wsdg on Teladoc Health ·

You’ve overlooked the activist investor factor. Travis Cocke’s Voss has announced 5% ownership through a 13G filing. They’ve added to that 5% since, and in doing so, have created a structural trap door for 27.42 Million Shares actively sold short. Chuck will announce lots of positives on July 29 but it’s what Voss announces shortly after that will rock the overextended Teledoc shorts. The Walmart partnership is the tip of the iceberg. The market is missing the sheer regulatory and enterprise friction of modern corporate healthcare. Teladoc isn't a "consumer app"; it is the primary digital infrastructure integrated directly into the legacy backends of Tier-1 insurance companies and fortune 500 employers, covering 105 million+ lives. Teladoc is acting as the digital top-of-funnel engine for the world's largest retailer. If Voss pushes the narrative that Teladoc is effectively the outsourced digital brain of Walmart's entire healthcare footprint, the fair value shifts from a basic health multiple to an enterprise distribution premium. Additionally , we are in a structural gold rush for high-quality, legally compliant, longitudinal medical data to train vertical healthcare AI models. Large technology hyperscalers and pharmaceutical giants cannot simply scrape the internet for this; they need structured clinical inputs. Teladoc sits on one of the largest de-identified virtual medical datasets on earth. From the activist playbook , we’ll see Voss demand the immediate creation of a Data & Diagnostics Licensing Division, transforming a legacy liability into an incredibly high-margin, pure-software data asset that requires zero human clinician hours to scale. Chuck is doing great work and deserves credi5 for the Teledoc turnaround but it will be Travis Cocke who will be responsible for a share price way beyond your $15 valuation.

1
|
0